Paperonium

Bowel cancer · Cancer Res · 2022

A study’s summary says 18 human tumors grown in mice were treated. The paper lists 15.

18The summary3tumors the paper never describes15Its own four groups, added up6234
18The summary3tumors the paper never describes15Its own four groups,added up6234

Patients’ bowel tumors grown in mice and given the pair of drugs

The paper says

To test cancer drugs, researchers grew pieces of patients’ bowel tumors in mice. The paper’s summary says a pair of drugs was given to 18 of these tumors and 60% shrank, meeting the goal the study set in advance.

Its own data show

Everywhere else the paper counts 15: its four groups by gene mutation (6 + 2 + 3 + 4), its figure captions, and two tables naming each tumor. No other tumor appears anywhere. Its results say 9 of the 15 (60%) shrank by at least 30%. 60% of 18 would be 10.8 tumors.

The number of tumors tested is the size of the evidence: fewer tumors, more room for luck. Researchers pooling studies usually take that number from the summary, so they would count 3 tumors this paper never describes. The result holds: the goal was over 3 in 10 tumors shrinking by 30% or more; 9 in 15 is 6 in 10.

“The summary” means the paper’s abstract: the short summary printed at its top, which is the part most readers see.

Read the paper →Full technical write-up →

Targeting RAS Mutant Colorectal Cancer with Dual Inhibition of MEK and CDK4/6 · Cancer Res (2022) · doi:10.1158/0008-5472.CAN-22-0198